Article Information
History
- July 13, 2022.
Article Versions
- Version 1 (September 3, 2021 - 13:34).
- Version 2 (October 29, 2021 - 10:43).
- Version 3 (December 13, 2021 - 08:56).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shannen van Duijn1,*,
- Hellen C. Barsosio2,
- Mevis Omollo2,
- Emmanuel Milimo3,
- Isdorah Akoth2,
- Robert Aroka3,
- Teresa de Sanctis1,
- Alloys K’Oloo2,
- Micah J. June2,
- Nathalie Houben3,
- Charlotte Wilming1,
- Kephas Otieno2,
- Simon Kariuki2,
- Simon Onsongo4,
- Albert Odhiambo5,
- Gregory Ganda5 and
- Tobias F. Rinke de Wit1
- 1PharmAccess Foundation, Amsterdam Office, Paasheuvelweg 25, 1105 BP, Amsterdam, the Netherlands
- 2Kenya Medical Research Institute (KEMRI), Center for Global Health Research (CGHR), P.O. Box: 1578 - 40100, Kisumu, Kenya
- 3PharmAccess Foundation Kenya Office, Cairo Road, Milimani, 40100, Kisumu, Kenya
- 4Aga Khan Hospital Kisumu, Kisumu, Kenya
- 5Department of Health, Kisumu County Government P.O. Box 2738-40100, Kisumu, Kenya
- ↵*Corresponding Author
All correspondence related to this manuscript can be directed towards Shannen van Duijn, M.Sc. PharmAccess Foundation, Paasheuvelweg 25, 1105BP, Amsterdam. shannenvanduijn{at}gmail.com
Posted July 13, 2022.
Public-private partnership to rapidly strengthen and scale COVID-19 response in Western Kenya
